CIK: 0001232621
Total reported value
$2.0B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HRTX | Heron Therapeutics INC | Stock-Other | 44.29% | -0.15% | — | |
| 2 | LJPC | La Jolla Pharmaceutical Co | Stock-Other | 31.49% | — | +4.56% | |
| 3 | ✓ | Ignyta INC | Stock-Other | 10.36% | — | — | |
| 4 | OPK 3 02-01-33 AI | Opko Health INC | Stock-Other | 9.14% | — | — | |
| 5 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 3.46% | — | — | |
| 6 | ✓ | Cyclacel Pharmaceuticals INC | Stock-Other | 0.90% | — | — | |
| 7 | LIFEUSD | Atyr Pharma INC | Stock-Other | 0.37% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LJPC | La Jolla Pharmaceutical Co | +9.7% | +4.56% | Add |
| 2 | ✓ | Ignyta INC | +0.8% | — | Unchanged |
| 3 | OPK 3 02-01-33 AI | Opko Health INC | +0.3% | — | Unchanged |
| 4 | BMRN | Biomarin Pharmaceutical INC | +0.3% | — | Unchanged |
| 5 | LIFEUSD | Atyr Pharma INC | 0% | — | Unchanged |
| 6 | HRTX | Heron Therapeutics INC | -5.6% | — | Unchanged |
| 7 | BABA | Alibaba Group Holding-sp Adr | — | EXIT | Sold out |
| 8 | MACK 4.5 07-15-20 | Merrimack Pharmaceuti | — | EXIT | Sold out |
| 9 | NKTREUR | Nektar Therapeutics | — | EXIT | Sold out |
| 10 | ✓ | Cyclacel Pharmaceuticals INC | — | NEW | New buy |
| 11 | BCRX | Biocryst Pharmaceuticals INC | — | EXIT | Sold out |
| 12 | ✓ | Lipocine INC New | — | EXIT | Sold out |
| 13 | ✓ | Celldex Therapeutics INC New | — | EXIT | Sold out |